Klaire Labs Interfase; Enzyme Supplement; Packaged in 60 and 120 Vegetarian capsules…

ProThera, Inc. recalled this product and the FDA reported the enforcement action on 20 November 2013 as Class II. The recall was initiated by the firm. ProThera was notified by enzymes provided by Specialty Enzymes within the last 3-6 months may be contaminated with chloramphenicol.

The record

Every field below is published by the FDA in the openFDA food enforcement database. Check the FDA notice before acting on any recall: this page is a reading of the public record, not a substitute for it.

Product

Klaire Labs Interfase; Enzyme Supplement; Packaged in 60 and 120 Vegetarian capsules bottles. UPC 60 ct.- 7 0961 012270 7; UPc 120 ct. - 7 09616-01229 1 Manufactured by ProThera, Inc., , Klaire Labs is a division of ProThera Reno, NV 89521

Reason for recall

ProThera was notified by enzymes provided by Specialty Enzymes within the last 3-6 months may be contaminated with chloramphenicol.

Recalling firm

ProThera, Inc.

Firm location

Reno, Nevada, United States

Classification

Class II

Status

Terminated

Recall number

F-0161-2014

Quantity

243,851

Distribution

US and Australia, Azerbaijan, Brazil, Canada, Germany, Great Britain, Hong Kong, Ireland (Eire, Japan, Malaysia, Malta, Mexico, New Zealand, Panama, Philippines, Russia, South Korea, Spain, Switzerland, Thailand.

Initiated

10 October 2013

Reported by FDA

20 November 2013

Terminated

24 February 2014

Firm notified by

Letter

Product codes

Lot #' 313127

Reading this record

Five things about this record are not in the record itself, and each one changes how it should be read.

• Class II means the FDA judged a remote probability of serious harm, or a probability of temporary or medically reversible harm. The class is assigned by an agency health hazard evaluation under 21 CFR 7.41, not by the firm.
• The firm started this recall itself. Most FDA food recalls are voluntary, and a recall is a food safety plan working rather than failing. The circumstances in which the agency asks for one instead are set out in 21 CFR 7.45.
• This is one of 5 records covering the same recall event. The FDA opens one enforcement record per product code, so a recall of a product line appears here many times. Counting these records as 5 separate recalls, which almost every published figure does, overstates it by a factor of 5. Every product code in this event is listed together on the record that covers the whole recall, which is the page a search engine is pointed to for all 5 of them.
• The recall ran for 5 months, from 10 October 2013 to termination on 24 February 2014. Termination means the agency judged that all reasonable effort had been made, under 21 CFR 7.55, and it says nothing about whether product remained in circulation.
• The FDA published the enforcement report 6 weeks after the firm began the recall.
• Recalls of a dietary supplement run a median of 15 months, so this one was shorter than usual for its category. Dietary supplements are regulated under their own good manufacturing practice rule, 21 CFR part 111, and they are the only food category where the dominant recall reason is an ingredient that was never declared because it is a pharmaceutical.

Filed under dietary supplements. A product can sit in more than one.

Other dietary supplements recalls

These are the closest records in the corpus: the same kind of food. Unlike the firm’s own records below, they come from different companies, which is what makes them a pattern rather than a history.

Other records from ProThera, Inc.

The FDA opens one enforcement record per product code, so several of these are frequently one recall event. 8 other records name this firm.

All 9 records for ProThera, Inc.

All 2013 recalls · All FDA food recall data